Sun Pharma
Sun Pharmaceutical Industries Ltd. (Sun Pharma) is a multinational pharmaceutical company headquartered in Mumbai, India. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States. The company offers formulations in various therapeutic areas, such as cardiology, psychiatry, neurology, gastroenterology and diabetology. It also provides APIs such as warfarin, carbamazepine, etodolac, and clorazepate, as well as anticancers, steroids, peptides, sex hormones, and controlled substances.
History[edit | edit source]
Sun Pharma was established by Dilip Shanghvi in 1983 in Vapi with five products to treat psychiatry ailments. Cardiology products were introduced in 1987 followed by gastroenterology products in 1989. Today, it is the largest chronic prescription company in India and a market leader in psychiatry, neurology, cardiology, orthopedics, ophthalmology, gastroenterology and nephrology.
Acquisitions[edit | edit source]
Over the years, Sun Pharma has made several acquisitions in the pharmaceutical industry, including Ranbaxy Laboratories in 2014, which made it the largest pharmaceutical company in India, the largest Indian pharmaceutical company in the US, and the 5th largest specialty generic company globally.
Research and Development[edit | edit source]
Sun Pharma's global presence is supported by 41 manufacturing facilities spread across 6 continents, R&D centers across the globe and a multi-cultural workforce comprising over 50,000 employees. The R&D center has capabilities for developing bio-equivalent generic drugs, novel drug delivery systems (NDDS) and new chemical entities (NCEs).
Controversies[edit | edit source]
Sun Pharma has faced several controversies, including issues related to corporate governance and insider trading allegations. In 2018, a whistleblower complaint to the Securities and Exchange Board of India (SEBI) alleged that Sun Pharma indulged in irregularities and corporate governance lapses.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
